Login / Signup
Jilin Xing
ORCID
Publication Activity (10 Years)
Years Active: 2019-2019
Publications (10 Years): 1
Top Topics
Ischemia Reperfusion Injury
Breast Cancer Cells
Nuclear Factor
Positive Breast Cancer
Top Venues
Cancer medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Jilin Xing
,
Ji Li
,
Lin Fu
,
Junda Gai
,
Jingqian Guan
,
Qingchang Li
SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.
Cancer medicine
8 (16) (2019)